Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-01

Clinical Trial Update: Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy [NA]

View source ↗

Summary

A clinical trial comparing oral hydration to intravenous hydration for prevention of contrast-induced nephropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Prof. Dr. J. Wetzels | Conditions: Radiographic Contrast Agent Nephropathy | NA | Status: TERMINATED